$20.00 USD

The link for the webinar workshop will be available on the page immediately after registration and be emailed to the address listed: I understand that there are no refunds offered for this event. I acknowledge it is my responsibility to ensure that my calendar is marked and link is saved for the event.

Subscribe to email for important product and member updates (recommended)

Stimulants and Psychedelics - Focus and Surrender

Join a live webinar workshop focused on the intersection of stimulants and psychedelics.

Workshop Logistics

The live webinar workshop will take place 10a-12p CST on Saturday Feb 17th
Workshop will consist of a 75-90 min lecture, short break, 20-30 min case discussion, and 30 min Q&A session.
Access to a webpage with a copy of the recording and PDF slides for download are included in registration
Members of the Resource and Support Program can attend via the Member Portal and do not need to register to attend

Workshop Overview:

Psychostimulants (Stimulants) have long histories of use and have both recreational and therapeutic purposes. Used since time immemorial for increased stamina, wakefulness, or euphoric effects, contemporarily, they are commonly prescribed drugs for the management of Attention Deficit and Hyperactivity Disorders (ADHD), although are also used in psychiatry for treatment of narcolepsy, adjunctively to serotonin reuptake blocking antidepressants (e.g., bupropion) when fatigue is bothersome, or for management of binge-eating disorders (e.g., lisdexamfetamine).

While psychedelic assisted therapy (PAP) has not targeted ADHD, narcolepsy, or binge eating disorder in studies to date, many persons report microdosing psychedelics such as psilocybin or LSD for management of ADHD. Furthermore, psilocybin is being studied for the management of treatment resistant depression (TRD), body dysphoria, and several types of addictive disorders, thus may play a role in the management for several of these conditions soon.

Both psychedelics and stimulants can work to increase or boost monoamine neurotransmission and can raise cardiovascular parameters, yet their psychological effects on focus or attention, ego tonicity, and cortical processing are distinct. Overall, there is likely to be drug interaction potential between the two classes that may require skillful management to reduce harms and improve outcomes of psychedelic therapy.

This webinar aims to summarize medical literature pertaining to how stimulants and psychedelics interact with each other. The official objectives for this webinar are to:

Define stimulant mechanisms of action and summarize their interaction potential with commonly used psychedelics
Discuss strategies for management of stimulants in the context of psychedelic therapy including tapering or temporarily suspending use
Explore potential for psychedelic therapies to interface with attention deficit or stimulant use disorders

There will be no refunds issued for the event in the circumstances you're unable to attend. Registration will trigger emails that have the workshop information containing the attendance link. The attendance link will also be available on the webpage immediately following registration. It is your responsibility to follow up at [email protected] if you do not receive these emails at least 24 hours prior to the event. In the case of gross technical difficulties or other circumstances (e.g., illness, medical emergency) significantly effecting the workshop quality or precluding its occurrence, the workshop will be rescheduled to a different time.

This webinar is for information and educational purposes only. It is not meant to condone or encourage the use of illicit substances. The information presented is not medical advice and should not be taken as such. It is recommended you follow laws applicable to your jurisdiction.